Literature DB >> 10027909

Parathyroid hormone and mechanical usage have a synergistic effect in rat tibial diaphyseal cortical bone.

Y Ma1, W S Jee, Z Yuan, W Wei, H Chen, S Pun, H Liang, C Lin.   

Abstract

Previous reports showed that bone mass and architecture only partially recovered by remobilization (RM) after immobilization (IM)-induced osteopenia, and that parathyroid hormone (PTH) had an anabolic effect on the skeleton. The aim of this study was to determine whether low doses of PTH could restore IM-induced cortical bone loss and whether a combination of PTH plus loading (RM) treatment would be more effective than the PTH in unloaded (IM) limbs. One hundred and sixty 6-month-old rats were divided into aging and IM groups. The right hindlimb of the rat was immobilized by elastic bandage for 18 weeks, and then groups of rats were either kept IM or RM and treated with 30 microgram or 80 microgram of hPTH(1-38)/kg/day for 2, 10, and 20 weeks. Fluorescent-labeled, undecalcified cross-sections of right tibial shafts were studied. We found that RM for 20 weeks after 18 weeks of IM only partially recovered IM-induced muscle weight loss and PTH had no effect on muscle weight in either IM or RM limbs; that RM for 20 weeks after 18 weeks of IM partially restored some minimal cortical width by stimulating periosteal and endocortical bone formation and decreasing endocortical resorption; that PTH treatment of IM limbs completely restored IM-induced cortical bone loss and added extra bone by stimulating bone formation indices on all bone surfaces and depressing bone resorption on endocortical surface; that PTH treatment of RM limbs produced similar anabolic effects as in IM limbs with 30 microgram/kg/day dose but the 80 microgram/kg/day dose-treated limbs had a higher periosteal bone formation rate, which created a larger cross-sectional area, more cortical bone area, and a thicker cortex than the same dose treated IM limbs; and that PTH 80 microgram/kg/day treatment produced more anabolic effect than the 30 microgram/kg/day in both IM and RM limbs. We concluded that reloading the hindlimb by RM after long-term IM could not recover the cortical bone mass. PTH at employed doses was able to completely restore IM-induced cortical bone loss, and this effect was independent of mechanical stimulation. However, when PTH was combined with mechanical loading (RM), a synergistic anabolic effect on periosteal bone formation occurred which increased the cross sectional area that can increase bone strength.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10027909     DOI: 10.1359/jbmr.1999.14.3.439

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  18 in total

1.  Effect of impact exercise on bone metabolism.

Authors:  A Vainionpää; R Korpelainen; H K Väänänen; J Haapalahti; T Jämsä; J Leppäluoto
Journal:  Osteoporos Int       Date:  2009-03-05       Impact factor: 4.507

2.  Parathyroid hormone regulation of hypoxia-inducible factor signaling in osteoblastic cells.

Authors:  Alice Wong; Gabriela G Loots; Clare E Yellowley; Andréa C Dosé; Damian C Genetos
Journal:  Bone       Date:  2015-07-04       Impact factor: 4.398

3.  Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats.

Authors:  Yankel Gabet; David Kohavi; Ralph Müller; Michael Chorev; Itai Bab
Journal:  Osteoporos Int       Date:  2005-04-06       Impact factor: 4.507

Review 4.  Bone mechanotransduction may require augmentation in order to strengthen the senescent skeleton.

Authors:  Sundar Srinivasan; Ted S Gross; Steven D Bain
Journal:  Ageing Res Rev       Date:  2012-01-05       Impact factor: 10.895

5.  Do antiosteoporotic drugs improve bone regeneration in vivo?

Authors:  Maximilian Leiblein; Dirk Henrich; Florian Fervers; Kerstin Kontradowitz; Ingo Marzi; Caroline Seebach
Journal:  Eur J Trauma Emerg Surg       Date:  2019-04-26       Impact factor: 3.693

Review 6.  Osteocytic signalling pathways as therapeutic targets for bone fragility.

Authors:  Lilian I Plotkin; Teresita Bellido
Journal:  Nat Rev Endocrinol       Date:  2016-05-27       Impact factor: 43.330

7.  Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study.

Authors:  Joy N Tsai; Alexander V Uihlein; Sherri-Ann M Burnett-Bowie; Robert M Neer; Yuli Zhu; Nicholas Derrico; Hang Lee; Mary L Bouxsein; Benjamin Z Leder
Journal:  J Bone Miner Res       Date:  2015-01       Impact factor: 6.741

8.  Altered trabecular bone morphology in adolescent and young adult athletes with menstrual dysfunction.

Authors:  Deborah M Mitchell; Padrig Tuck; Kathryn E Ackerman; Natalia Cano Sokoloff; Ryan Woolley; Meghan Slattery; Hang Lee; Mary L Bouxsein; Madhusmita Misra
Journal:  Bone       Date:  2015-06-27       Impact factor: 4.398

9.  Effect of prior and ongoing raloxifene therapy on response to PTH and maintenance of BMD after PTH therapy.

Authors:  F Cosman; J W Nieves; M Zion; N Barbuto; R Lindsay
Journal:  Osteoporos Int       Date:  2007-10-11       Impact factor: 4.507

10.  Role of parathyroid hormone in the mechanosensitivity of fracture healing.

Authors:  Michael J Gardner; Marjolein C H van der Meulen; Joshua Carson; Jonathan Zelken; Benjamin F Ricciardi; Timothy M Wright; Joseph M Lane; Mathias P Bostrom
Journal:  J Orthop Res       Date:  2007-11       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.